CIHR announces $40M cancer stem cell funding
The Cancer Stem Cell Consortium (CSCC) announced today a collaborative funding arrangement with the California Institute for Regenerative Medicine (CIRM).The co-funding initiative will “support the research of multi-disciplinary teams of scientists, co-led by Canadian and Californian Principal Investigators that will result in a cancer stem cell based therapy or a therapy derived from cancer stem cell assays with the specific aim of improving cancer treatment”. The CSCC will provide $40-million as the Canadian contribution to up to two projects for a period up to four years, with the CIRM providing matching funds.
The CSCC is an agency funded by CFI, CIHR, Genome Canada, OICR, and the Stem Cell Network. This is the first funding opportunity administered by the CSCC. Applications will be made through the CIRM here. Based on the information on the CIRM website, NOIs are due just eight days after the announcement – Feb 25.
